New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Vivesto AB
OASMY
Shape
US Flag

PNK

Unprofitable

Unprofitable

13M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

13M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

0.05USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

304%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

99%

Quote Panel

Shape
Updated October 16, 2024
1W 0.00 % 1M -1.80 % 3M -1.80 % 1Y 24400.00 %

Key Metrics

Shape
  • Market Cap

    12.88M


  • Shares Outstanding

    262.96M


  • Share in Float

    377.31M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.049


  • Average Volume

    421


  • Beta

    0.523


  • Range

    2.0E-4-0.05


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.vivesto.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

19.67x

P/S Ratio

0.52x

P/B Ratio

0.0

Debt/Equity

-1415.4%

Net Margin

$-0.1

EPS

How OASMY compares to sector?

P/E Ratio

Relative Strength

Shape

OASMY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$0.02

Shape-269%

2025-EPS

$941K

Shape2%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

NA
vs NA

Q2.22

arrow
arrow

N/A

-0.02
vs NA

Q3.22

arrow
arrow

N/A

-0.04
vs NA

Q4.22

arrow
arrow

N/A

-0.02
vs NA

Q1.23

arrow
arrow

N/A

-0.01
vs NA

Q2.23

arrow
arrow

N/A

-0.02
vs -0.02

Q3.23

arrow
arrow

N/A

-0.01
vs -0.04

Q4.23

arrow
arrow

N/A

-0.03
vs -0.02

Q1.24

arrow
arrow

N/A

-0.00
vs -0.01

Q2.24

arrow
arrow

N/A

-0.01
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-100%

NA  vs 4.4K

Q2.22

arrow
arrow

-100%

NA  vs 546.3K

Q3.22

arrow
arrow

-93%

96.2K  vs 1.4M

Q4.22

arrow
arrow

-82%

194.1K  vs 1.1M

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

-93%

7K  vs 96.2K

Q4.23

arrow
arrow

+234%

648.1K  vs 194.1K

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.06

Q4.22

arrow
arrow

-9%

-0.09
vs -0.14

Q1.23

arrow
arrow

-7%

-0.07
vs -0.09

Q2.23

arrow
arrow

-10%

-0.10
vs -0.07

Q3.23

arrow
arrow

-6%

-0.06
vs -0.10

Q4.23

arrow
arrow

-31%

-0.31
vs -0.06

Q1.24

arrow
arrow

-5%

-0.05
vs -0.31

Q2.24

arrow
arrow

-6%

-0.06
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.17

arrow
arrow

4

4
vs 4

NA

Q4.17

arrow
arrow

5

5
vs 4

25%

Q1.18

arrow
arrow

3

3
vs 5

-40%

Q2.18

arrow
arrow

4

4
vs 3

33%

Q3.18

arrow
arrow

4

4
vs 4

NA

Q4.18

arrow
arrow

4

4
vs 4

NA

Q1.19

arrow
arrow

6

6
vs 4

50%

Q2.19

arrow
arrow

3

3
vs 6

-50%

Earnings Growth

Latest News